In obesity, the altered levels of numerous molecules inhibit osteoblastogenesis, as TNFα, DKK1, sclerostin, IL-6, serotonin, and advanced glycation end products (AGEs) [revised in Roy et al. (63)]. The gene discussed is TNF; the disease is obesity disorder.